The mission of the Immuno-Oncology Working Group is to strengthen the interactions between Cancer Center investigators who work in tumor immunology and immuno-oncology.

The UFHCC has developed a Microbiome Working Group that discusses exciting news within the microbiome – new breakthroughs or high impact publications – while fostering collaborations.

The mission of the Targeted Therapeutics Working Groups is to facilitate development of targeted therapeutic approaches to improve treatments of cancer.

The mission of the Myeloid Working Group is to catalyze myeloid neoplasia research through hypothesis-driven, collaborative and translational clinical trials.